ELIGO BIOSCIENCE
Eligobiotics is a developer of antibiotics intended to treat microbiome precision and bacteria-associated diseases. The company's antibiotics combine CRISPR/Cas system with engineered phage capsids, to develop antimicrobials that are used to eradicate resistant pathogens or virulent bacteria within the human microbiome, enabling clients to get next-generation antimicrobials to treat diseases caused by superbugs.
ELIGO BIOSCIENCE
Industry:
Biotechnology Health Care Medical
Founded:
2014-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.eligo.bio
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
39.81 M USD
Technology used in webpage:
SPF SSL By Default Euro IPv6 Google Apps For Business US Privacy User Signal Mechanism Google Google Cloud Cloudflare Hosting Cloudflare DNS
Current Advisors List
Current Employees Featured
Founder
Investors List
CARB-X
CARB-X investment in Grant - Eligo Bioscience
European Commission
European Commission investment in Grant - Eligo Bioscience
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Eligo Bioscience
Seventure Partners
Seventure Partners investment in Series A - Eligo Bioscience
Khosla Ventures
Khosla Ventures investment in Series A - Eligo Bioscience
Worldwide Innovation Challenge
Worldwide Innovation Challenge investment in Grant - Eligo Bioscience
Seventure Partners
Seventure Partners investment in Seed Round - Eligo Bioscience
Worldwide Innovation Challenge
Worldwide Innovation Challenge investment in Seed Round - Eligo Bioscience
AGORANOV
AGORANOV investment in Angel Round - Eligo Bioscience
Official Site Inspections
http://www.eligo.bio Semrush global rank: 5.77 M Semrush visits lastest month: 1.45 K
- Host name: 104.21.32.172
- IP address: 104.21.32.172
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
